Related Links Educational Materials About Clinical Trials Clinical Trials Questions to Ask Your Doctor Drug Information from MedlinePlus

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Registry Information

Alternate Title

Randomized Study of Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Cancer Survivors Who Continue to Smoke

Basic Trial Information

Phase	Type	Status	Age	Sponsor	Protocol IDs
No phase specified	Prevention	Closed	18 and over	NCI	NCI-03-C-N308 NCT00079469

Trial Description

Purpose:

Contingency management is a behavioral treatment approach that provides immediate rewards for positive change in behavior such as quitting smoking. In this protocol, contingency management will be in the form of a cash reward. A smoking cessation (stop-smoking) program that combines contingency management with bupropion and counseling may be effective in helping cancer survivors stop smoking.

Randomized clinical trial to compare the effectiveness of bupropion and counseling with or without contingency management in helping cancer survivors stop smoking.

Eligibility:

• At least 18 years old
• At least 6 months since cancer diagnosis
• Smoked for at least 2 years, and daily for the past month
• At least 6 months, but no more than 5 years, since completing cancer treatment
• No use of tobacco products other than cigarettes more than once a week
• For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Patients will be randomly assigned to one of two groups.

Patients in group one will receive bupropion by mouth twice a day for 12 weeks. During this time, they will also receive short counseling sessions on how to quit smoking .

Patients in group two will receive bupropion and counseling as in group one. They will also receive a money reward for not smoking.

Patients will be evaluated 6 and 12 weeks after completing the stop-smoking program.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

NCI - Center for Cancer Research

Glen Morgan, PhD, Principal investigator		Ph: 301-451-5048 Email: gmorgan@nih.gov
Sandra Schaefer, RN, BSN, OCN, Study coordinator		Ph: 301-451-5048 Email: schaefes@mail.nih.gov

Registry Information
Official Title		Contingency Management to Enhance Smoking Cessation for Cancer Survivors: A Proof of Concept Trial
Trial Start Date		2004-02-10
Registered in ClinicalTrials.gov		NCT00079469
Date Submitted to PDQ		2004-02-10
Information Last Verified		2004-07-16

Back to Top